SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data, presented at the World Muscle Society congress, reported slower upper-limb decline after patients switched to deramiocel, drawing attention to the investigational Duchenne muscular dystrophy therapy. Traders largely reacted bullishly and viewed the findings as support ahead of the FDA review, while some questioned whether the extension data address the agencys statistical concerns.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths transition from the Armada SPAC to Nasdaq trading as an XRP treasury company is driving attention, with traders focused on its XRP holdings and potential exposure through common shares and warrants. The community is largely bullish on the XRP-linked opportunity, while some question valuation and warn of SPAC-related volatility and uncertainty.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A DEA judges pause in the broader cannabis Schedule I-to-III rescheduling case, while considering whether to add a GAO report on agency procedures to the record, has delayed a closely watched catalyst for MSOS and cannabis operators. Traders debate whether the stay is a serious setback or a procedural delay that leaves rescheduling possible, with some reacting to the selloff by buying the dip and others expecting further weakness.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas choice of Amazon Leo over Starlink and reported criticism of Elon Musk are driving discussion, with some traders questioning the decision as United expands Starlink WiFi and citing poor connectivity on Delta flights. A few also speculate about CEO accountability, but the communitys reaction is mixed and the reported remarks are not independently verified here.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCNs sharp move higher has traders anticipating a breakout, with bullish posts pointing to altcoin momentum and Zebecs payroll and payment utility. Speculation about Robinhood or BlackRock involvement remains unconfirmed, while others warn the move could retrace or prove short-lived.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly results beat expectations and lifted its full-year outlook, while record bookings pointed to resilient cruise demand and drove a sharp rally. Bulls welcomed the results and booking strength, while skeptics remained concerned about fuel costs, debt, and pressure on margins.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Reported takeover interest from Lundbeck has sparked heavy speculation about a potential Xeris sale or bidding war, although no deal is confirmed and the company has said it is not for sale. Traders are divided over whether the interest could lead to an offer, with some questioning Lundbecks ability to finance an acquisition and others viewing the companys response as negotiating posture.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings selection for the U.S. Navys next-generation F/A-XX fighter program is driving attention, with traders viewing the multibillion-dollar development award as a boost to its defense business and shares. Some remain cautious, arguing that the contracts promise depends on execution and does not resolve Boeings commercial-aircraft and production challenges.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Taus completion of enrollment in its expanded IMPACT pancreatic-cancer studyenlarged from 12 to 48 patients amid reported clinician and patient demandis driving discussion, alongside anticipated glioblastoma and other clinical updates and a possible FDA IDE for its Keytruda combination. Traders are broadly bullish on the pipeline and momentum, while noting that key data and regulatory developments are still pending.

Six Flags Entertainment Corp. engages in operating amusement parks in North America. It operates amusement parks, water parks, and resorts. The company is headquartered in Charlotte, NC.

Six Flags Entertainment Corp.

Six Flags Entertainment Corp

JANA Partners call for Six Flags to explore a sale is driving discussion, with traders debating whether a transaction could unlock value or distract management from operational execution and debt reduction. The debate is unfolding alongside continued share-price weakness and concerns about the companys heavy debt load.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rocket Doctor AI Inc. (CSE: AIDR, OTC: $AIRDF ) recorded 3,625 completed U.S. patient visits in July and August 2026, equal to 93 percent of its entire second quarter total, in an operational update released ahead of the global Company Town Hall scheduled for Monday, September 14, 2026. The update follows the second quarter results the company reported on September 1, 2026, and puts the July and August figures in the public domain ahead of the session. 
 
Rocket Doctor AI Inc. is a B2i Digital Featured Company. See the company&#39;s in-depth profile at: https://b2idigital.com/rocket-doctor-inc-1 
 
Two United States operating measures for July and August stand against the full three months of the second quarter: 
 
• The 3,625 completed U.S. patient visits cover the two-month period ending August 31, 2026, compared with 3,911 completed visits recorded for the entire second quarter of 2026 
 
• U.S. clinical hours increased to 1,555 hours for the two months ending August 31, 2026, representing 78 percent of the 1,987.5 clinical hours recorded for the entire second quarter of 2026 
 
Read the full release: https://www.globenewswire.com/news-release/2026/09/14/3361023/0/en/rocket-doctor-ai-provides-operational-update-for-u-s-operations-for-first-two-months-of-q3-2026-ahead-of-global-company-town-hall.html 
 
Rocket Doctor AI Inc. delivers physician-guided, AI-powered solutions built to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of its proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide, alongside a digital health platform and marketplace that has helped more than 350 physicians support over 750,000 patient visits. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. 
 
B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer.

David Shapiro

Kier Golino

Cody Mundorff

Den Tongco

fariha jabeen

Bonnie Siegmund

Linda Scott

Ariana Storck

Craig Salinas

Eugene Davenport

Michael Musto

Roberta Creech

Henry Callaghan

John Park

Melissa Vermillion

Shirley Hall

Jeanne Hodges

Micheal Fikes

James Adair

Kelly Distaffen

Renee Blankenship

Nina Studdard

Filomena Marsh

Lucy Pena

Raymond Oliver

Terry Skora

Amber Reilly

Edwina Packard

Karen Paris

Rocket Doctor, Inc. (OCTQB: AIRDF) a Featured Profile on B2i Digital

B2idigital

Rocket Doctor, Inc. | OCTQB: AIRDF | B2i Digital Featured Company

Vancouver, B.C., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI" or the "Company"),...

GlobeNewswire News Room

Rocket Doctor AI Provides Operational Update for U.S. Operations for First Two Months of Q3 2026 Ahead of Global Company Town Hall

b2i digital - connecting companies and investors through digital marketing, investor conferences, and direct introductions and meetings.

B2i Digital - Connecting companies and investors

Disclaimer - Content is provided "as is" by companies featured on the site. Conduct a trusted advisory before making investments.

Disclaimer - Consult an advisor before making any investments

StockTwits Web

Rocket Doctor AI Inc.

 ) recorded 3,625 completed U.S. patient visits in July and August 2026, equal to 93 percent of its entire second quarter total, in an operational update released ahead of the global Company Town Hall scheduled for Monday, September 14, 2026. The update follows the second quarter results the company reported on September 1, 2026, and puts the July and August figures in the public domain ahead of the session. 
 
Rocket Doctor AI Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: 

 
 
Two United States operating measures for July and August stand against the full three months of the second quarter: 
 
• The 3,625 completed U.S. patient visits cover the two-month period ending August 31, 2026, compared with 3,911 completed visits recorded for the entire second quarter of 2026 
 
• U.S. clinical hours increased to 1,555 hours for the two months ending August 31, 2026, representing 78 percent of the 1,987.5 clinical hours recorded for the entire second quarter of 2026 
 
Read the full release: 

 
 
Rocket Doctor AI Inc. delivers physician-guided, AI-powered solutions built to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of its proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide, alongside a digital health platform and marketplace that has helped more than 350 physicians support over 750,000 patient visits. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at 

. 
 
B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://

Rocket Doctor AI’s latest update shows strong momentum in its U.S. operations, with 3,625 completed patient visits in just two months, reaching 93% of the entire second-quarter total. 
 
With AI-powered healthcare and a growing physician network, the company is building an interesting model for accessible digital care. 
See Rocket Doctor AI’s full profile on B2i Digital at: https://b2idigital.com/rocket-doctor-inc-1

Rocket Doctor AI’s latest update shows strong momentum in its U.S. operations, with 3,625 completed patient visits in just two months, reaching 93% of the entire second-quarter total. 
 
With AI-powered healthcare and a growing physician network, the company is building an interesting model for accessible digital care. 
See Rocket Doctor AI’s full profile on B2i Digital at: 